LXRX Projected Dividend Yield
Lexicon Pharmaceuticals, Inc. ( NASDAQ : LXRX )Lexicon Pharmaceuticals, Inc. is a biopharmaceutical company. Co. is focused on the discovery, development, and commercialization of pharmaceutical products for the treatment of human disease. Co. pipeline includes INPEFA (sotagliflozin), LX9211, and LX9851. Sotagliflozin is an orally delivered small molecule compound that is being developed for the treatment of heart failure and type I diabetes, and type II diabetes mellitus, chronic kidney disease and other cardiovascular risk factors. LX9211 is an orally delivered small molecule compound that is being developed for the treatment of neuropathic pain. 20 YEAR PERFORMANCE RESULTS |
LXRX Dividend History Detail LXRX Dividend News LXRX Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |